Nelson Vergel
Founder, ExcelMale.com
The pill has been twice rejected, but Sprout Pharmaceuticals said Tuesday, Feb. 17, 2015, it is refiling its application for flibanserin, adding new information requested by the Food and Drug Administration about how the pill affects driving ability. Drugmakers frequently cite a 1999 survey in the Journal of the American Medical Association that found 43 percent of U.S. women had some type of sexual dysfunction.
Sprout said Tuesday it is refiling its application for flibanserin, adding new information requested by the FDA about how the pill affects driving ability. FDA scientists requested that data after their most recent rejection of the drug, in part, due to results showing nearly 10 percent of women in company trials reported sleepiness as a side effect.
After lobbying push, drugmaker resubmits women’s sex pill
WASHINGTON (AP) — The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women’s groups and consumer advocates …
www.sandiegouniontribune.com
